• 구독신청
  • My스크랩
  • 지면신문
FNTIMES 대한민국 최고 금융 경제지
ad

LS, L&F Reunite Founding Families in Business After 18 Years

정진아 기자

urzinnie@fntimes.com

기사입력 : 2026-08-10 09:54

LS-L&F Battery Joint Venture
Saemangeum's LLBS to Begin Mass Production This Year
Precursor "KRW 1 Trillion Alliance" Gamble

AI generated

AI generated

이미지 확대보기
[Korea Financial Times, Jung Jina] Two of Korea's most prominent business families — the Neungseong Koo clan and the Gimhae Heo clan — have joined hands again, 18 years after their corporate split. The result is LS-L&F Battery Solution (LLBS), a joint venture established in Saemangeum three years ago.

LS and L&F set up the precursor-production joint venture LS-L&F Battery Solution (LLBS) in October 2023, aiming to secure raw material supply stability and strengthen supply chain competitiveness. Precursor material is produced by combining nickel, cobalt and manganese, and serves as the core material in the stage immediately before cathode material production.

LLBS began trial operations at its Saemangeum plant in March last year. With a total investment exceeding KRW 1 trillion, the company plans to start mass production this year and expand annual capacity to 120,000 tons by 2029.

LS holds 55% of the joint venture and L&F 45%. As LLBS remains at the pre-commercial production stage, it posted revenue of KRW 224 million and a net loss of KRW 9.2 billion last year. L&F is effectively its only customer — the KRW 224.42 million worth of raw materials L&F purchased from LLBS last year nearly matches LLBS's total revenue for the year.

The joint venture marks the first time the Koo and Heo families have come together again since they officially split in 2005 through the separation of the LG and GS business groups — 18 years ago.

Chairman Koo Ja-eun, the third-generation head of LS Group, is leading the conglomerate under a "two-handed management" strategy that pursues both its core businesses — wire and cable, power infrastructure — and future growth areas such as batteries, electric vehicles and semiconductors.

CEO Heo Je-hong, a fourth-generation manager from the broader GS family, has built L&F into a global cathode material company. His late father, Heo Jeon-su, chairman of Saeronix, was a cousin of Huh Chang-soo, honorary chairman of GS Group — the two surnames "Heo" and "Huh" being alternate romanizations of the same Korean family name (許). Heo Je-hong took a more active role in management after his father's death in 2010.

The uneven equity split in favor of LS reflects differences in capital strength. L&F has long been seen as having a relative weakness in securing the large-scale funding needed to build out its raw material supply chain.

The 55:45 equity ratio set at the joint venture's founding in 2023 has remained unchanged through subsequent capital increases. In a 2024 capital injection, LS contributed KRW 59.95 billion and L&F KRW 49.05 billion, each in proportion to its respective stake.

The two companies also signed a shareholders' agreement. If either party sells its stake in LLBS, the other is granted a right of first refusal, and both sides can exercise tag-along rights. The agreement also includes a call-option clause allowing one party to buy out the other's stake in the event of a breach of contract.

For Chairman Koo Ja-eun, the joint venture completes a battery value chain running from nickel sulfate (LS MnM) to precursor material (LLBS) to cathode material (L&F).

L&F, for its part, is working to build a supply chain that meets overseas regulatory requirements, and the domestic joint venture is aimed at stabilizing that supply chain.

L&F's own value-chain reorganization took place around the same time. Saeronix sold its entire 24.61% stake in precursor affiliate JH Chemical to L&F last year.

JH Chemical also produces precursor material by combining nickel, cobalt and manganese, putting it in the same business area as LLBS. The move is widely interpreted as an effort to consolidate the group's scattered precursor-related holdings into a single entity, LLBS.

Of L&F's total raw material purchases last year — KRW 2.1212 trillion — precursor-inclusive raw materials such as NCM accounted for 99.53%, or KRW 2.1113 trillion. That heavy reliance on stable raw material supply, which is directly tied to the company's bottom line, was also a factor behind the joint venture.

Jung Jina (urzinnie@fntimes.com)

데일리 금융경제뉴스 FNTIMES - 저작권법에 의거 상업적 목적의 무단 전재, 복사, 배포 금지
Copyright ⓒ 한국금융신문 & FNTIMES.com

가장 핫한 경제 소식! 한국금융신문의 ‘추천뉴스’를 받아보세요~

KFT Topic 다른 기사

1 LG Chem Petrochemicals Face Losses Despite NCC Restart; Advanced Materials Recovering Petrochemicals is once again LG Chem’s main concern. While earnings at its battery subsidiary and advanced materials business are improving, its petrochemicals division, which returned to profit in the first half, is expected to slip back into the red in the second half. The No. 2 naphtha cracking center (NCC) plant in Yeosu, idled for about six months, has resumed operations. But a profit recovery looks difficult as the negative inventory lag effect from falling feedstock prices and higher logistics costs weigh on results.According to financial data provider FnGuide on the 22th, the consensu 2 Hanwha Systems Raises KRW 3.4 Trillion as It Winds Down ‘Bridge’ Role in Hanwha Ocean Deal Hanwha Systems is raising KRW 3.4 trillion through a price return swap (PRS) on its Hanwha Ocean shares and the sale of its stake in the Philly shipyard in the United States. Both assets came out of Hanwha Systems’ efforts to back the Hanwha Group’s push to strengthen its shipbuilding business. The company is now expected to end its “bridge” role and concentrate on strengthening its core business through capital reallocation.According to the investment banking (IB) industry on Oct. 20, Hanwha Systems recently decided to transfer all 22,169,660 of its Hanwha Ocean common shares to Kiwoom Se 3 Hanmi Pharm Hit by Shareholder Feud, Rights Return; Next Obesity Drug Key to Rebound Hanmi Pharm is facing a double blow, a dispute among its major shareholders and the return of rights to a key pipeline asset, and has slipped into a valuation discount.While solid core profitability provides a cushion, further out-licensing of follow-up obesity drugs and a resolution of governance risk are expected to be the main turning points for a revaluation.Inheritance Tax Sparked the Feud, Now a KRW 60 Billion LawsuitHanmi Pharmaceutical Group’s operating environment is clouded from every direction, industry sources said on Oct. 18. The governance risk began after the death of founder L
ad
ad
ad

한국금융 포럼 사이버관

더보기

FT카드뉴스

더보기
[그래픽 뉴스] ‘순대’가 경제용어라고? 순(純)대외자산, 한국의 진짜 해외자산은 얼마일까?
[그래픽 뉴스] ISA 대개편! 나에게 유리한 계좌는?
[그래픽 뉴스] 미국 증시 새로운 키워드 'MANGOS'
환전·로또·육아휴직까지 하반기부터 달라지는 제도 TOP11
[그래픽 뉴스] 은퇴후 30년 부모님 세대의 생존전략

FT도서

더보기